1. Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative 
Ellen M. Denzen, Navneet S. Majhail, Stacy Stickney Ferguson, Claudio Anasetti, Arthur Bracey, Linda Burns, Richard Champlin, Jeffrey Chell, Helen Leather, Michael Lill, Richard T. Maziarz, Erin Medoff, Joyce Neumann, Kim Schmit-Pokorny, Edward L. Snyder, Laura Wiggins, Deborah S. Yolin Raley, Elizabeth A. Murphy 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 1, Pages 4-11 (January 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 HCT in 2020: System Capacity Initiative.
(Reprinted with permission. [1])
Biology of Blood and Marrow Transplantation  , 4-11DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
System Capacity Initiative workforce recommendations: impact on capacity.
Biology of Blood and Marrow Transplantation  , 4-11DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Unmet need for allogeneic HCT in US transplant center market areas. The figure shows adult patients (age 20-54, all diagnoses) within each market area who potentially needed HCT and did not receive one. Each market area is defined by a Thiessen polygon, in which boundaries are defined by the perpendicular bisectors of the lines connecting the location of adjacent transplant centers.
Biology of Blood and Marrow Transplantation  , 4-11DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions